首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   28541篇
  免费   2148篇
  国内免费   134篇
耳鼻咽喉   177篇
儿科学   770篇
妇产科学   730篇
基础医学   3640篇
口腔科学   747篇
临床医学   2807篇
内科学   5893篇
皮肤病学   438篇
神经病学   3084篇
特种医学   1073篇
外科学   3867篇
综合类   434篇
一般理论   22篇
预防医学   2604篇
眼科学   430篇
药学   1724篇
中国医学   37篇
肿瘤学   2346篇
  2023年   295篇
  2022年   440篇
  2021年   869篇
  2020年   595篇
  2019年   803篇
  2018年   913篇
  2017年   684篇
  2016年   771篇
  2015年   784篇
  2014年   1155篇
  2013年   1452篇
  2012年   2281篇
  2011年   2273篇
  2010年   1189篇
  2009年   994篇
  2008年   1770篇
  2007年   1723篇
  2006年   1523篇
  2005年   1523篇
  2004年   1384篇
  2003年   1180篇
  2002年   1101篇
  2001年   398篇
  2000年   378篇
  1999年   363篇
  1998年   244篇
  1997年   167篇
  1996年   168篇
  1995年   153篇
  1994年   138篇
  1993年   127篇
  1992年   278篇
  1991年   230篇
  1990年   193篇
  1989年   187篇
  1988年   159篇
  1987年   177篇
  1986年   159篇
  1985年   167篇
  1984年   105篇
  1983年   124篇
  1982年   68篇
  1981年   72篇
  1979年   81篇
  1978年   80篇
  1974年   72篇
  1973年   62篇
  1972年   74篇
  1971年   80篇
  1968年   63篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Emergency Medicine staff in Australia and New Zealand are at the forefront of the healthcare response to COVID‐19. This article describes a well‐being plan for ED staff that has been devised to mitigate against the negative psychological impact of the COVID‐19 pandemic.  相似文献   
3.
4.
5.
6.
7.

Objective

To determine whether differences in combination DTaP vaccine types at 2, 4 and 6?months of age were associated with mortality (all-cause or non-specific), within 30?days of vaccination.

Design

Observational nationwide cohort study.

Setting

Linked population data from the Australian Childhood Immunisation Register and National Death Index.

Participants

Australian infants administered a combination trivalent, quadrivalent or hexavalent DTaP vaccine (DTaP types) between January 1999 and December 2010 at 2, 4 and 6?months as part of the primary vaccination series. The study population included 2.9, 2.6, & 2.3?million children in the 2, 4 and 6?month vaccine cohorts, respectively.

Main outcome measures

Infants were evaluated for the primary outcome of all-cause mortality within 30?days. A secondary outcome was non-specific mortality (unknown cause of death) within 30?days of vaccination. Non-specific mortality was defined as underlying or other cause of death codes, R95 ‘Sudden infant death syndrome’, R96 ‘Other sudden death, cause unknown’, R98 ‘Unattended death’, R99 ‘Other ill-defined and unspecified cause of mortality’ or where no cause of death was recorded.

Results

The rate of 30?day all-cause mortality was low and declined from 127.4 to 59.3 deaths per 100,000 person-years between 2 and 6?month cohorts. When compared with trivalent DTaP vaccines, no elevated risk in all-cause or non-specific mortality was seen with any quadrivalent or hexavalent DTaP vaccines, for any cohort.

Conclusion

Use of routine DTaP combination vaccines with differing disease antigens administered during the first six months of life is not associated with infant mortality.  相似文献   
8.
Ovarian cancer is the fourth most common cause of cancer-related death in women in the developed world, and one of the most heritable cancers. One of the most significant risk factors for epithelial ovarian cancer (EOC) is a family history of breast and/or ovarian cancer. Combined risk factors can be used in models to stratify risk of EOC, and aid in decisions regarding risk-reduction strategies. Germline pathogenic variants in EOC susceptibility genes including those involved in homologous recombination and mismatch repair pathways are present in approximately 22% to 25% of EOC. These genes are associated with an estimated lifetime risk of EOC of 13% to 60% for BRCA1 variants and 10% to 25% for BRCA2 variants, with lower risks associated with remaining genes. Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) thought to explain an additional 6.4% of the familial risk of ovarian cancer, with 34 susceptibility loci identified to date. However, an unknown proportion of the genetic component of EOC risk remains unexplained. This review comprises an overview of individual genes and SNPs suspected to contribute to risk of EOC, and discusses use of a polygenic risk score to predict individual cancer risk more accurately.  相似文献   
9.
Maternal and Child Health Journal - Background Prenatal substance use screening is recommended. The 4 P’s Plus screener includes questions on perceived problematic substance use in parents...  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号